Top Story

Reproductive span tied to type 2 diabetes risk in postmenopausal women

July 28, 2016

Women who experience menopause before age 46 years or after age 55 years or who have a reproductive span shorter or longer than 30 to 45 years are at increased risk for developing type 2 diabetes, according to an analysis of Women’s Health Initiative data.

Age at menarche and menstrual cycle regularity were not associated with diabetes risk.

In the Journals Plus

Lifestyle intervention improves health-related quality of life in prediabetes, metabolic syndrome

July 28, 2016
Adults with prediabetes or metabolic syndrome assigned to an intensive 12-month lifestyle intervention program saw improvements in health-related quality of life, as…
In the Journals Plus

Portion-size preference does not determine BMI

July 28, 2016
Adults with overweight do not choose larger food portions than their normal-weight peers, according to recent findings. “Large portions of food are often blamed…
In the Journals Plus

Later-onset menarche, menopause associated with longevity

July 28, 2016
Women with later-onset menarche, later natural or surgical menopause and a longer reproductive lifespan are more likely to live to age 90 years vs. women with…
FDA News

FDA approves Adlyxin for type 2 diabetes

July 28, 2016
The FDA has approved the once-daily glucagon-like peptide-1 receptor agonist Adlyxin, a once-daily injection to improve glycemic control along with diet and exercise in…
More News Headlines »
CME Video

Secondary Prevention of Atherothrombotic Events: Current Insights on Advancing Science

This activity is supported by an educational grant from Merck & Co.

Prevention of cardiovascular disease (CVD) is critical in light of its associated mortality, morbidity, and economic…
More »
Meeting News Coverage

VIDEO: ADA's Safe at School campaign making progress

June 10, 2016
More »
Highlights from AACE

Highlights from AACE


Obesity Consults® ObesityForum® 2015 Highlights

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Novo Nordisk, Inc.

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »
Current Issues
View the Current Issues